We are live on
!
Find out more
Allogene Therapeutics
ALLO
ALLO
172 hedge funds and large institutions have $223M invested in Allogene Therapeutics in 2025 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
524% more call options, than puts
Call options by funds: $281K | Put options by funds: $45K
45% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 20
15% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 46
11% more capital invested
Capital invested by funds: $201M → $223M (+$21.7M)
1% more funds holding
Funds holding: 170 → 172 (+2)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.68% less ownership
Funds ownership: 73.06% → 72.38% (-0.68%)
Holders
172
Holders Change
+2
Holders Change %
+1.18%
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
29
Increased
53
Reduced
46
Closed
20
Calls
$281K
Puts
$45K
Net Calls
+$236K
Net Calls Change
+$164K
Top Buyers
| 1 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.04M |
| 2 |
PSC
Patient Square Capital
Menlo Park,
California
|
+$2.61M |
| 3 |
Goldman Sachs
New York
|
+$1.43M |
| 4 |
Primecap Management
Pasadena,
California
|
+$1.4M |
| 5 |
Jane Street
New York
|
+$1.25M |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.88M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.45M |
| 3 |
Millennium Management
New York
|
-$2.04M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.49M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.38M |
